• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways.

作者信息

Leblanc Kori, MacGillivray Jenny, Carroccia Amanda, Macle Laurent, Andrade Jason G

机构信息

University Health Network, Toronto, Ontario.

Vancouver General Hospital, Vancouver, BC.

出版信息

Can Pharm J (Ott). 2021 Nov 17;155(2):107-118. doi: 10.1177/17151635211058160. eCollection 2022 Mar-Apr.

DOI:10.1177/17151635211058160
PMID:35300017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8922222/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/58e992a79e77/10.1177_17151635211058160-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/d9a3a0fc4846/10.1177_17151635211058160-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/1092f5c256f7/10.1177_17151635211058160-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/8e5190ba272d/10.1177_17151635211058160-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/18bd8d8dfa11/10.1177_17151635211058160-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/323a818659db/10.1177_17151635211058160-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/58e992a79e77/10.1177_17151635211058160-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/d9a3a0fc4846/10.1177_17151635211058160-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/1092f5c256f7/10.1177_17151635211058160-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/8e5190ba272d/10.1177_17151635211058160-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/18bd8d8dfa11/10.1177_17151635211058160-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/323a818659db/10.1177_17151635211058160-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef5/8922222/58e992a79e77/10.1177_17151635211058160-fig6.jpg

相似文献

1
The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways.2020年药剂师CCS心房颤动指南：十大要点
Can Pharm J (Ott). 2021 Nov 17;155(2):107-118. doi: 10.1177/17151635211058160. eCollection 2022 Mar-Apr.
2
Performance of the "CCS Algorithm" in real world patients.“CCS算法”在真实世界患者中的表现。
Int J Cardiol Heart Vasc. 2015 Feb 7;7:18-21. doi: 10.1016/j.ijcha.2015.02.001. eCollection 2015 Jun 1.
3
Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.在药房使用苹果手机心电图进行房颤筛查：实施情况的定性综述
Int J Clin Pharm. 2015 Dec;37(6):1111-20. doi: 10.1007/s11096-015-0169-1. Epub 2015 Jul 23.
4
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.加拿大心血管学会 2012 年心房颤动指南重点更新：卒中预防和节律/心率控制推荐。
Can J Cardiol. 2012 Mar-Apr;28(2):125-36. doi: 10.1016/j.cjca.2012.01.021.
5
Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project.预测心房颤动合并阻塞性慢性冠状动脉综合征患者的死亡率：比亚韦斯托克冠状动脉项目
J Clin Med. 2021 Oct 26;10(21):4949. doi: 10.3390/jcm10214949.
6
Comparing the 2010 North American and European atrial fibrillation guidelines.比较 2010 年北美和欧洲心房颤动指南。
Can J Cardiol. 2011 Jan-Feb;27(1):7-13. doi: 10.1016/j.cjca.2010.11.009.
7
Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study.心房颤动意识宣传活动为药剂师提供早期检测机会：一项国际横断面研究。
J Thromb Thrombolysis. 2020 May;49(4):606-617. doi: 10.1007/s11239-019-02000-x.
8
The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines.《2014年心房颤动指南指南手册：应用加拿大心血管学会指南的实用方法》
Can J Cardiol. 2015 Oct;31(10):1207-18. doi: 10.1016/j.cjca.2015.06.005.
9
Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines.全球心房颤动管理：当前 ACCF/AHA/HRS、CCS 和 ESC 指南的比较。
Europace. 2011 Oct;13(10):1368-74. doi: 10.1093/europace/eur172. Epub 2011 Jun 28.
10
A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale.一种用于在床边评估房颤症状严重程度的新型简易量表：CCS-SAF量表。
Can J Cardiol. 2006 Apr;22(5):383-6. doi: 10.1016/s0828-282x(06)70922-9.

引用本文的文献

1
The role of pharmacists in the management of patients with atrial fibrillation: A systematic review and meta-analysis.药剂师在心房颤动患者管理中的作用：一项系统评价和荟萃分析。
Can Pharm J (Ott). 2025 Aug 31:17151635251365148. doi: 10.1177/17151635251365148.
2
Safety and efficacy of direct oral anticoagulants in chronic kidney disease: a meta-analysis.直接口服抗凝剂在慢性肾脏病中的安全性和有效性：一项荟萃分析。
Res Pract Thromb Haemost. 2024 Oct 9;8(7):102584. doi: 10.1016/j.rpth.2024.102584. eCollection 2024 Oct.
3
Family Physician Prescribing Practices and Perspectives on Shared Decision-Making Regarding the Use of Oral Anticoagulants for Stroke Prevention in Patients 75 Years or Older With Atrial Fibrillation.

本文引用的文献

1
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.2020 年加拿大心血管学会/加拿大心律学会心房颤动管理综合指南。
Can J Cardiol. 2020 Dec;36(12):1847-1948. doi: 10.1016/j.cjca.2020.09.001. Epub 2020 Oct 22.
2
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association.药物性心律失常：美国心脏协会的科学声明。
Circulation. 2020 Oct 13;142(15):e214-e233. doi: 10.1161/CIR.0000000000000905. Epub 2020 Sep 15.
3
Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies.
家庭医生在 75 岁及以上伴有心房颤动的患者中预防卒中使用口服抗凝药物方面的处方实践和共同决策观点。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231164060. doi: 10.1177/21501319231164060.
房颤患者口服抗凝剂的依从性：观察性研究的系统评价和荟萃分析。
BMJ Open. 2020 Apr 8;10(4):e034778. doi: 10.1136/bmjopen-2019-034778.
4
The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews.药师护理对初级保健环境中糖尿病结局的影响：已发表系统评价的伞式综述。
Prim Care Diabetes. 2020 Oct;14(5):393-400. doi: 10.1016/j.pcd.2019.12.007. Epub 2020 Jan 8.
5
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.合并慢性肾脏病和心房颤动患者的抗凝治疗：美国心脏病学会评论专题之周更。
J Am Coll Cardiol. 2019 Oct 29;74(17):2204-2215. doi: 10.1016/j.jacc.2019.08.1031.
6
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.依度沙班与维生素 K 拮抗剂在房颤患者成功经皮冠状动脉介入治疗后抗栓治疗方案的比较（ENTRUST-AF PCI）：一项随机、开放标签、3b 期临床试验。
Lancet. 2019 Oct 12;394(10206):1335-1343. doi: 10.1016/S0140-6736(19)31872-0. Epub 2019 Sep 3.
7
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.心房颤动合并稳定性冠心病的抗栓治疗。
N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2.
8
Meta-Analysis of Direct-Acting Oral Anticoagulants Compared With Warfarin in Patients >75 Years of Age.直接口服抗凝剂与华法林在>75 岁患者中的比较的荟萃分析。
Am J Cardiol. 2019 Jun 15;123(12):2051-2057. doi: 10.1016/j.amjcard.2019.02.060. Epub 2019 Mar 18.
9
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.心房颤动急性冠状动脉综合征或经皮冠状动脉介入治疗后的抗血栓治疗。
N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.
10
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.在体重处于极端范围的房颤患者中，阿哌沙班与华法林的疗效和安全性。
Circulation. 2019 May 14;139(20):2292-2300. doi: 10.1161/CIRCULATIONAHA.118.037955.